Shares of Moderna Inc. MRNA, +3.95% rose 3.96% to $78.29 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index COMP, -0.10% falling 0.10% to 11,863.90 and Dow Jones Industrial Average DJIA, -0.54% falling 0.55% to 28,679.81. This was the stock’s fifth consecutive day of gains. Moderna Inc. closed $16.92 below its 52-week high ($95.21), which the company reached on July 17th.
The stock outperformed some of its competitors Tuesday, as AbbVie Inc. ABBV, -0.55% fell 0.55% to $87.83 and Amgen Inc. AMGN, -0.07% fell 0.07% to $239.34. Trading volume (13.6 M) eclipsed its 50-day average volume of 10.7 M.